TrialClinical and translational science2025

Safety, Pharmacokinetics, and Immunogenicity of Astegolimab, an Anti-ST2 Monoclonal Antibody, in Randomized, Phase I Clinical Studies.

Wenhui Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.